MedTrace Logo

Treatment of Patients With Trophic Ulcers Using Mesenchymal Stem Cells

NCT04457037 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2020-07-07

No results posted yet for this study

Summary

Treatment of patients with trophic ulcers using injection of autologous adipose-derived mesenchymal stem cells around and inside the wound

Conditions

  • Trophic Ulcer

Interventions

BIOLOGICAL

Autologous adipose-derived mesenchymal stem cells

Autologous adipose-derived mesenchymal stem cells

Sponsors & Collaborators

  • Belarusian State Medical University

    collaborator OTHER

  • Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

    lead OTHER_GOV

Principal Investigators

  • Igor Volotovski, Dr · Head of the Lab of Institute of Biophysics and Cell Engineering

  • Stanislav Tretyak, Prof · Head of 2 Department of Surgical Diseases of BSMU

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-01
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Belarus

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04457037 on ClinicalTrials.gov